Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review

Repici, Alessandro; Hassan, Cesare; Pessoa, D De Paula; Pagano, Nico; Arezzo, Alberto; Zullo, Angelo; Lorenzetti, Roberto; Marmo, Riccardo

doi:10.1055/s-0031-1291448

Cited by 262 publications

(216 citation statements)

References 13 publications

Supporting

Mentioning

194

Contrasting

Unclassified

Order By: Relevance

“…Tis-Tumore) und Submukosakarzinomen erschwert [533]. Vergleichende retrospektive und daher nicht randomisierte Studien der ESD mit der EMR gibt es ebenfalls nur aus Fernost [534 -540].…”

Section: Polypektomiedurchführungunclassified

S3-Leitlinie – Kolorektales Karzinom

Schmiegel

Buchberger

Follmann³

et al. 2017

Z Gastroenterol

148

View full text Add to dashboard Cite

“…Tis-Tumore) und Submukosakarzinomen erschwert [533]. Vergleichende retrospektive und daher nicht randomisierte Studien der ESD mit der EMR gibt es ebenfalls nur aus Fernost [534 -540].…”

Section: Polypektomiedurchführungunclassified

S3-Leitlinie – Kolorektales Karzinom

Schmiegel

Buchberger

Follmann³

et al. 2017

Z Gastroenterol

148

View full text Add to dashboard Cite

“…If SNNS is clinically developed as a safe surgical approach based on the findings obtained, the clinical application of SNNS will be extensively extended among patients with early gastric cancer. Furthermore, advances have been made in endoscopic treatments for patients with early malignancies, including gastric cancer 35, 36. Therefore, ESD with laparoscopic SBD may become the ultimate stomach‐preserving surgery for avoiding lymph node recurrence in selected patients with extended indications for ESD; however, further studies are needed prior to its expansion as a surgical approach.…”

Section: Future Prospects For Snns As a Minimally Invasive Approachmentioning

confidence: 99%

Novel surgical approach based on the sentinel node concept in patients with early gastric cancer

Natsugoe

Arigami

Uenosono

et al. 2017

Annals of Gastroent Surgery

View full text Add to dashboard Cite

Recent prospective multicenter trials have demonstrated the clinical safety and efficacy of sentinel node navigation surgery (SNNS) in patients with early gastric cancer. Further, development of an intraoperative imaging system and an indocyanine green fluorescence imaging approach has been attracting attention as a novel tool for detection of the sentinel node (SN). The greatest advantage of an in vivo imaging system is that it visualizes SN and afferent lymphatic vessels from the primary tumor site more clearly than the conventional dye approach. Besides visualization of the SN, it is also essential to accurately assess the presence or absence of lymph node metastasis in the intraoperative management of SNNS. However, the clinical significance of lymph node micrometastasis (LNM) in patients with gastric cancer remains controversial. Reverse transcription‐polymerase chain reaction (RT‐PCR) is one of the representative assays used to identify LNM. A rapid RT‐PCR assay that completes the detection of LNM within approximately 40 minutes has recently been produced and applied in the clinical management of SNNS. From the viewpoint of surgical methods, modified laparoscopic and endoscopic cooperative surgery with non‐exposed approaches has recently been highlighted as a promising technique to prevent tumor dissemination caused by surgical procedures, and is likely to be clinically applied to SNNS in the future. When carrying out SNNS as a minimally invasive surgery, it is important to consider the balance between post‐surgical quality of life and curability. Future prospective studies on SNNS will greatly contribute to furthering its establishment as a beneficial procedure for patients with early gastric cancer.

show abstract

“…Saito et al consider ESD indicated in LST-G mixed larger than 3 cm (42). Other indications for ESD include mucosal lesions with submucosal fibrosis secondary to prior resections, biopsies or associated with inflammatory bowel disease (43). In those cases, the risk of perforation or leaving a residual lesion is higher if ESD is not performed.…”

Section: Colon and Rectummentioning

confidence: 99%

Endoscopic submucosal dissection: Sociedad Española de Endoscopia Digestiva (SEED) clinical guideline

Fernández‐Esparrach¹,

Calderón

Peña

et al. 2014

Rev. esp. enferm. dig.

View full text Add to dashboard Cite

Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review

Abstract: ESD appeared to be an extremely effective technique to achieve R0 resection of large colorectal lesions. The very low rate of surgery for complications also shows the potential safety of this approach.

Cited by 262 publications

References 13 publications

S3-Leitlinie – Kolorektales Karzinom

S3-Leitlinie – Kolorektales Karzinom

Novel surgical approach based on the sentinel node concept in patients with early gastric cancer

Endoscopic submucosal dissection: Sociedad Española de Endoscopia Digestiva (SEED) clinical guideline

Contact Info

Product

Resources

About